In February 2025, Occam Global, a leader in TechBio executive recruiting, placed Sudhir Rao as Chief Business Officer of Envisagenics, an AI-driven biotechnology company revolutionizing RNA splicing research and therapeutics.
Rao brings over 30 years of experience in the life sciences industry, with the last 15 years in business development, spanning both buy-side and sell-side positions in large pharma and small biotech across disease states. He has held business positions of increasing responsibility in multiple organizations, including most recently being SVP/Head of Business Development at Expansion Therapeutics, VP of Business Development at Genocea Biosciences, and Transactions Lead at Takeda Pharmaceuticals.
Rao earned his BA in Biochemistry, his MS in Epidemiology/Virology from the University of Virginia, and his MBA from the Questrom School of Business at Boston University.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.